Features of Investment in medicine.

Features of Investment in medicine.

Emelianenko Elena director of the company SYNOPSIS +7 (495) 774-59-11 www.medresearch.ru Today, Russia has achieved a significant private capital, has become a good habit to talk about investments in new technologies and innovations. Usually, it comes to computer and network technologies, communication systems and products designed for general consumers. Projects in these segments most demanded by the market, investors are willing to allocate to them the means justified the hope for a quick profit. Another advantage of such investments - a developed system of consulting, serving the sponsors and investors. "But what about medicine?" - You ask. Do not inventors and innovators in this area? Of course, there are innovative projects in this area, but investors are very reluctant to risk their funding. It would seem that a successful project in the field of medicine has enormous potential for profitability, and its positive social component is obvious. But, alas, investors are able to evaluate the prospects of a particular invention in this industry is extremely small, because consultants in the market there is little, but the authors of the projects are not always able to present their ideas in a purely commercial point of view. Historically, the authors of innovative projects in medicine - the scientists - researchers, inventors, doctors, not businessmen (though these are encountered, but rarely). Unlike their western counterparts in basic business education, and market-oriented Russian inventors do not always think about the practical side of the issue and in developing guided purely scientific interest. More often they simply do not know how their ideas to "sell". Indeed, the investor is difficult to understand the language of medical terminology, and assess the importance of the discovery or technology from a scientific point of view. The businessman is guided by other criteria, rather than medical scientists. And, despite the fact that the goals of the inventor and the sponsor are not mutually exclusive, and sometimes even a closer look the same, the difference between the concepts can hinder meaningful dialogue between them. At the moment, innovative medical technologies in Russia developed with the participation of a few investors, companies importing foreign innovations, and finally, domestic inventors. As mentioned above, some investors and they do not operate safely. Still, interest in medicine is, it can and should be expanded. Private companies-importers act as representatives of foreign companies that are already strong enough and can afford the development of new markets. Certainly, modern medicine is unthinkable without many Western technology, but the nature of their activities, these enterprises are not interested development of domestic scientists and not engage in investment. The inventors are looking for sponsors, and, unfortunately, do not always find them. We can not deny some very specific difficulties associated with medical innovation.